| Characteristic | Anonymization of data | Approval by designated body | Data subject consent | Pseudonymization of data | Noncommercial exploitation | Limited to public sector researchers |
|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
Download
Source
Source
Release date
November 2025
More information
Region
Asia, Europe, EU
Survey time period
June 2024 to March 2025
Number of respondents
50 respondents
Age group
18 years and older
Method of interview
Questionnaire
Supplementary notes
The WHO Regional Office for Europe conducted a survey on AI in health systems between June 2024 and March 2025. The survey was addressed to all 53 Member States of the WHO European Region, and 50 Member States responded.
Citation formats
